Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Pathophysiology of Heart Failure01:17

Pathophysiology of Heart Failure

2.9K
Heart failure (HF) is a progressive syndrome involving ventricles that leads to inadequate cardiac output. It can be classified based on location and output or ejection fraction. Ejection fraction (EF) is an essential measurement in the diagnosis and surveillance of HF. Reduced EF corresponds to systolic heart failure (HFrEF). However, HF with preserved ejection fraction (HFpEF) is becoming increasingly prevalent. Also known as diastolic HF, this form of HF is related to aging. The...
2.9K
Heart Failure IV: Classification and Diagnostic Evaluation01:30

Heart Failure IV: Classification and Diagnostic Evaluation

321
Heart failure can be classified in various ways, with the most common classifications based on physical activity limitations, disease progression, severity, and treatment strategies.The Functional Classification of Heart Failure divides patients into four categories based on physical activity limitation due to symptom burden.Class I: Patients in this class have cardiac disease but no physical activity limitations. Ordinary activities like walking, climbing stairs, or routine tasks do not cause...
321
Heart Failure II: Pathophysiology01:29

Heart Failure II: Pathophysiology

730
Systolic Heart Failure and Compensatory MechanismsSystolic heart failure (also termed HFrEF, Heart Failure with Reduced Ejection Fraction) is the most prevalent type of heart filure. It results in a decreased volume of blood being pumped from the ventricle. The aortic arch and carotid sinuses have baroreceptors that detect reduced blood pressure, triggering the sympathetic nervous system (SNS) to release epinephrine and norepinephrine. Initially, this response aims to boost heart rate and...
730
Heart Failure I: Introduction01:27

Heart Failure I: Introduction

707
Heart failure refers to a clinical syndrome caused by structural or functional cardiac disorders that prevent the heart from pumping an adequate amount of blood to meet the body's metabolic needs. This condition often arises from myocardial infarction or ischemia, leading to decreased cardiac output, reduced tissue perfusion, impaired gas exchange, fluid volume imbalance, and decreased functional ability.Heart failure can result from disruptions in the mechanisms that regulate cardiac output...
707
Heart Failure III: Clinical Manifestations01:26

Heart Failure III: Clinical Manifestations

510
Heart failure (HF) manifests primarily as dyspnea, fatigue, and fluid retention, resulting in peripheral and pulmonary edema. Symptoms may vary depending on which ventricle is more affected, left or right.Left-Sided Heart FailureAlso known as left ventricular failure, this condition results from the left ventricle's inability to fill or eject sufficient blood into the systemic circulation. It leads to pulmonary congestion, which occurs when the left ventricle fails to eject blood effectively...
510
Cardiomyopathy III: Hypertrophic Cardiomyopathy01:29

Cardiomyopathy III: Hypertrophic Cardiomyopathy

411
Hypertrophic cardiomyopathy, or HCM, is an autosomal dominant genetic disorder characterized by asymmetric left ventricular hypertrophy without ventricular dilation. It is more common in men and is typically diagnosed in young, athletic adults.EtiologyHCM is primarily genetic and is caused by mutations in genes encoding sarcomeric proteins. Researchers have identified over 1400 mutations across at least 11 different genes. Among these, the most frequently occurring mutations are found in the...
411

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Acute High Intensity Interval Exercise Promotes Circulating Progenitor Cell Mobilization and Improves Microcirculation in Patients with Chronic Heart Failure.

Journal of cardiovascular development and disease·2026
Same author

A practical nomogram incorporating frontal QRS-T angle and aldosterone for early identification of cardiac sarcoidosis.

Heart & lung : the journal of critical care·2026
Same author

Quadruple therapy in heart failure: Why, when, and in whom?

Current problems in cardiology·2026
Same author

Comparative effectiveness of mineralocorticoid receptor antagonists in cardiovascular, renal and metabolic disease.

Current problems in cardiology·2026
Same author

Bioresorbable Scaffolds for Coronary Revascularization: From Concept to Clinical Maturity.

Journal of cardiovascular development and disease·2026
Same author

Impact of disease-modifying therapies on imaging parameters in cardiac amyloidosis: A systematic review and meta-analysis.

Current problems in cardiology·2026

Related Experiment Video

Updated: Jan 16, 2026

Lumped-Parameter and Finite Element Modeling of Heart Failure with Preserved Ejection Fraction
09:20

Lumped-Parameter and Finite Element Modeling of Heart Failure with Preserved Ejection Fraction

Published on: February 13, 2021

7.0K

One Syndrome, Many Faces: A Unified Perspective on Heart Failure Phenotypes.

Ioannis Paraskevaidis1,2, Elias Tsougos2, Christos Kourek1

  • 1Medical School of Athens, National and Kapodistrian University of Athens, 15772 Athens, Greece.

International Journal of Molecular Sciences
|September 27, 2025
PubMed
Summary

Heart failure (HF) is a single spectrum, not distinct syndromes. All heart failure phenotypes share common mechanisms, suggesting a unified approach to diagnosis and treatment is needed.

Keywords:
cardiovascular diseasediastolic dysfunctionheart failurephenotypic classificationpreserved ejection fraction

More Related Videos

A Surgical Model of Heart Failure with Preserved Ejection Fraction in Tibetan Minipigs
07:09

A Surgical Model of Heart Failure with Preserved Ejection Fraction in Tibetan Minipigs

Published on: February 18, 2022

2.3K
A Rat Model of Pressure Overload Induced Moderate Remodeling and Systolic Dysfunction as Opposed to Overt Systolic Heart Failure
07:13

A Rat Model of Pressure Overload Induced Moderate Remodeling and Systolic Dysfunction as Opposed to Overt Systolic Heart Failure

Published on: April 30, 2020

6.9K

Related Experiment Videos

Last Updated: Jan 16, 2026

Lumped-Parameter and Finite Element Modeling of Heart Failure with Preserved Ejection Fraction
09:20

Lumped-Parameter and Finite Element Modeling of Heart Failure with Preserved Ejection Fraction

Published on: February 13, 2021

7.0K
A Surgical Model of Heart Failure with Preserved Ejection Fraction in Tibetan Minipigs
07:09

A Surgical Model of Heart Failure with Preserved Ejection Fraction in Tibetan Minipigs

Published on: February 18, 2022

2.3K
A Rat Model of Pressure Overload Induced Moderate Remodeling and Systolic Dysfunction as Opposed to Overt Systolic Heart Failure
07:13

A Rat Model of Pressure Overload Induced Moderate Remodeling and Systolic Dysfunction as Opposed to Overt Systolic Heart Failure

Published on: April 30, 2020

6.9K

Area of Science:

  • Cardiology
  • Pathophysiology
  • Translational Medicine

Background:

  • Heart failure (HF) is traditionally classified into reduced (HFrEF), mildly reduced (HFmrEF), and preserved (HFpEF) phenotypes based on left ventricular ejection fraction (EF).
  • EF-based classification, while practical, faces challenges due to inconsistent definitions and blurring of categories in clinical trials.
  • This ambiguity hinders precise diagnosis and targeted treatment strategies for heart failure.

Purpose of the Study:

  • To challenge the traditional EF-based phenotyping of heart failure.
  • To propose a unified, mechanistically driven model of heart failure as a single entity with variable manifestations.
  • To explore common pathophysiological mechanisms across all HF phenotypes.

Main Methods:

  • Comprehensive review of existing literature on heart failure pathophysiology and clinical classifications.
  • Analysis of molecular, cellular, and systemic mechanisms implicated in different HF phenotypes.
  • Synthesis of evidence supporting a spectrum-based model of heart failure.

Main Results:

  • Emerging data indicate shared underlying mechanisms across all HF phenotypes, irrespective of EF.
  • Common pathways include neurohormonal activation, inflammation, mitochondrial dysfunction, fibrosis, and apoptosis.
  • The traditional EF categories may not accurately reflect distinct pathophysiological entities.

Conclusions:

  • Heart failure should be viewed as a single clinical syndrome with manifestations varying along a spectrum.
  • A unified, mechanistically driven model can improve diagnostic precision and therapeutic targeting in HF.
  • Reframing HF research based on shared mechanisms, rather than EF stratification, is crucial for advancing treatment.